期刊文献+

尖锐湿疣组织LTBP-1和TGF-βRⅡ的表达

Expression of latent transforming growth factor beta binding protein-1 and transforming growth factor beta type Ⅱ receptor in condyloma acuminatum tissues
原文传递
导出
摘要 目的探讨潜在结合蛋白(LTBP)-1及其Ⅱ型受体(TGF—βRⅡ)与尖锐湿疣发病的相关性。方法采用实时荧光定量PCR技术和SP免疫组化技术分别检测30例CA皮损及17例正常包皮组织中LTBP和TGF-βRⅡ的mRNA和蛋白的表达。结果CA皮损中LTBP-1及TGF-βRⅡ的mRNA的表达水平均低于对照组包皮组织(2^-△△α〉2)。免疫组化结果显示:LTBP-1和TGF—βRⅡ的染色强度较正常人包皮组织降低,差异有统计学意义(P〈0.01):结论LTBP-1和TGF—βRⅡ的表达下调,可导致TGF—β活化及信号转导通路的异常. Objective To investigate the role of the expression of latent transforming growth factor beta binding protein-1 (LTBP-1) and transforming growth factor beta receptor type Ⅱ (TGF-beta R Ⅱ ) in the pathogenesis of condyloma acuminatum (CA). Methods Samples were resected from the lesions of 30 patients with CA and prepuces of 17 normal human controls. The mRNA and protein expressions of LTBP-1 and TGF-betaR Ⅱ were assessed by quantitative real-time PCR and a streptavidin-biotin-peroxidase staining technique, respectively. Results As shown by Real time PCR, the mRNA expression levels of LTBP-1 and TGF-betaR Ⅱ were significantly higher in CA tissues than those in the controls, with the average value of 2 ^(-Delta Delta α) being 2.46 and 3.43, respectively. A lower intensity of stainning was observed for LTBP-1 and TGF-betaR Ⅱ in CA tissues compared with the normal controls (182.51 ± 9.89 vs 167.78 ± 12.56, 187.35 ± 11.23 vs 170.15 ± 13.21, t = 5.62, 3.70 respectively, both P 〈 0.01). Conclusion The decrease in the expression of both LTBP-1 and TGF-betaRⅡ may lead to the abnormality in the activation of TGF-beta and signal transduction pathways.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2008年第10期677-679,共3页 Chinese Journal of Dermatology
关键词 尖锐湿疣 转化生长因子Β 潜在性TGFβ结合蛋白质类 受体 转化生长因子 Condyloma acuminatum Transforming growth factor beta Latent TGF-beta binding proteins Receptor, transforming growth factors
  • 相关文献

参考文献6

二级参考文献11

  • 1俞小虹,郑伟,程浩.血管内皮生长因子及其受体在尖锐湿疣皮损中的表达[J].中华皮肤科杂志,2005,38(2):127-127. 被引量:2
  • 2张锡宝,罗权,吴志华,陈绍谦.血管内皮生长因子及其受体在银屑病发病中的作用及意义[J].中华皮肤科杂志,2005,38(3):140-142. 被引量:30
  • 3Chen S J,J Invest Dermatol,1999年,112卷,49页
  • 4Drijkoningen M.De Wolf-Peeters C.Degreef H.et a1.Epidermal Langerhans cells.dennal dendritic cells,and keratinocytes in viral lesions of skin and mucous membranes:an immunohistochemical study.Arch Dermatol Res,1998,280:220-227.
  • 5Banchereau J.Steinman RM.Dendritic cells and the control of immunity.Nature,1998,392:245—252.
  • 6Suss G.Shortman K.A subclass of dendritic cells kills CD4 T cells via Fas/Fas—ligand-induced apoptosis.J Exp Med.1996,183:1789-1796.
  • 7Steinbrink K,Jonuleit H,Mutter G,et al.Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+)T cells resulting in a failure to lyse tumor cells.Blood. 1999.93:1634-1642.
  • 8Moser M,Murphy KM.Dendritic cell regulation of TH1-TH2 development. Nat Immunol.2000.1:199—205.
  • 9Ballaun C,Weninger W,Uthman A,et al.Human keratinocytes express the three major splice forms of vascular endothelial growth factor.J Invest Dermatol,1995,104:7-10.
  • 10Benckert C,Jonas S,Cramer T,et al.Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells.Cancer Res,2003,63:1083-1092.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部